Prescription Required
Formulation: Capsule
(Brand Option)
Select the prescribed dosage
Select the quantity to see the price.
Prescription Required
Formulation: Capsule
Select the quantity to see the price.
* This price includes a dispensing fee, medical review fee, and packing fee.
Shipped and delivered directly to your doorstep
Prolopa is a prescription medication used to manage the symptoms of Parkinson’s disease, a progressive neurological condition that affects movement, coordination, and muscle control.
It contains two active ingredients: levodopa and benserazide. These medications work together to increase dopamine availability in the brain, helping improve movement and reduce symptoms such as tremors, muscle stiffness, and slowness of movement.
Prolopa belongs to a class of medications called antiparkinsonian agents, specifically dopamine replacement therapies.
Levodopa is converted into dopamine in the brain, while benserazide helps prevent levodopa from being broken down too early in other parts of the body.
This combination allows more levodopa to reach the brain and helps reduce certain side effects associated with levodopa treatment, including nausea and vomiting.
Prolopa helps control movement-related symptoms of Parkinson’s disease. However, it does not cure the condition or stop its progression.Â
Prolopa is primarily prescribed to treat Parkinson’s disease, a neurological condition that gradually affects the brain’s ability to control movement.
Parkinson’s disease develops when nerve cells in an area of the brain called the substantia nigra become damaged or die.
These nerve cells normally produce dopamine, a chemical messenger that helps coordinate smooth and controlled body movements.
As dopamine levels decrease, the brain has more difficulty sending signals that regulate muscle activity.
This can lead to symptoms such as tremors, muscle stiffness, slow movements, and problems with balance or coordination.
Patients with Parkinson’s disease may also experience difficulty walking, reduced facial expressions, changes in handwriting, and problems performing everyday activities.
Prolopa helps replace some of the missing dopamine by supplying levodopa, which is converted into dopamine after reaching the brain.
This can help improve movement, reduce stiffness, and make daily tasks easier.
However, the medication does not reverse the damage to dopamine-producing nerve cells.
Your healthcare provider will determine the appropriate dosage based on your symptoms, age, response to treatment, and other medications.
Prolopa helps improve movement and reduce symptoms of Parkinson’s disease by increasing dopamine availability in the brain.
Tremors are among the most recognizable symptoms of Parkinson’s disease.
A tremor is an involuntary shaking movement that commonly affects the hands, fingers, arms, or legs.
Parkinson’s tremors often occur when the affected body part is at rest and may become less noticeable during voluntary movement.
Some patients experience a characteristic movement of the thumb and fingers called a pill-rolling tremor.
Tremors can interfere with everyday activities, including holding objects, writing, dressing, and eating.
Prolopa helps increase dopamine levels in the brain, which may improve the control of involuntary movements.
However, the response to treatment varies, and some tremors may be more difficult to manage than other Parkinson’s symptoms.
Prolopa may help reduce Parkinson’s-related tremors, making certain everyday activities easier to perform.
Muscle rigidity is a common symptom of Parkinson’s disease that causes muscles to remain unusually tense or stiff.
This stiffness may affect the arms, legs, neck, shoulders, or other parts of the body.
Patients may experience discomfort, reduced flexibility, or difficulty moving their joints normally.
Muscle rigidity can also interfere with posture, walking, dressing, and other daily activities.
The condition develops partly because reduced dopamine activity disrupts the brain signals responsible for controlling muscle movement.
Prolopa helps restore dopamine signalling, allowing muscles to respond more normally to movement instructions.
As treatment becomes effective, some patients may experience reduced stiffness and improved flexibility.
Prolopa helps relieve muscle rigidity associated with Parkinson’s disease, improving movement and reducing stiffness-related discomfort.
Bradykinesia is a major symptom of Parkinson’s disease that causes movements to become unusually slow.
Patients with bradykinesia may have difficulty starting movements or completing simple daily tasks.
Activities such as getting dressed, standing up, walking, writing, or preparing meals may take longer than usual.
Some individuals may also experience reduced arm swinging while walking or smaller handwriting, known as micrographia.
Bradykinesia occurs because dopamine deficiency interferes with the brain’s ability to initiate and coordinate movement.
Prolopa helps increase dopamine levels, improving the communication between brain regions involved in motor control.
This may help patients move more easily, perform activities more efficiently, and maintain greater independence.
Prolopa is particularly effective at improving bradykinesia, helping patients initiate movements and perform daily activities more comfortably.
Parkinsonism is a general term used to describe a group of symptoms resembling Parkinson’s disease.
These symptoms may include tremors, rigidity, slow movements, and balance difficulties.
Although Parkinson’s disease is the most common cause of parkinsonism, similar symptoms can develop from other neurological disorders, medications, or medical conditions.
Some patients with non-drug-induced parkinsonian syndromes may benefit from levodopa treatment, depending on the underlying cause.
However, the response can vary considerably.
For example, certain atypical parkinsonian disorders may respond less effectively to levodopa than Parkinson’s disease.
It is also important to distinguish parkinsonism caused by medication from Parkinson’s disease itself.
Prolopa is not indicated for drug-induced parkinsonism under its Canadian product monograph. Drug-induced parkinsonism can occur as a side effect of certain medications, particularly those that block dopamine activity.
Treatment for drug-induced parkinsonism often involves reviewing or adjusting the medication responsible, under medical supervision.
Your healthcare provider will determine the underlying cause of your symptoms before recommending an appropriate treatment.
Prolopa may help selected patients with parkinsonian symptoms, but it is primarily indicated for Parkinson’s disease and should not be used to treat drug-induced parkinsonism.Â
Prolopa contains levodopa and benserazide, two medications that work together to improve dopamine availability in the brain.
Dopamine is a neurotransmitter that helps regulate movement, coordination, motivation, and other important functions.
In Parkinson’s disease, dopamine-producing nerve cells gradually deteriorate, resulting in reduced dopamine levels.
Prolopa helps compensate for this deficiency.
Levodopa: Helps Replace Dopamine
Levodopa is a precursor to dopamine, meaning the body can convert it into dopamine.
Unlike dopamine itself, levodopa can cross the blood-brain barrier, which protects the brain from many substances circulating in the bloodstream.
Once levodopa enters the brain, it is converted into dopamine.
This helps improve communication between nerve cells involved in controlling movement.
Increasing dopamine availability may reduce tremors, muscle stiffness, and slowness of movement.
Benserazide: Helps More Levodopa Reach the Brain
Benserazide is a peripheral dopa decarboxylase inhibitor.
It prevents much of the levodopa from being converted into dopamine before reaching the brain.
This is important because dopamine produced outside the brain cannot easily cross the blood-brain barrier.
By reducing levodopa conversion outside the brain, benserazide allows more levodopa to reach its intended destination.
It also helps reduce certain peripheral side effects of levodopa, particularly nausea and vomiting.
Combined Dopamine Replacement Therapy
Together, levodopa and benserazide help improve dopamine availability in the brain while reducing some unwanted effects that occur when levodopa is taken alone.
Prolopa works by converting levodopa into dopamine in the brain, while benserazide helps prevent premature levodopa breakdown elsewhere in the body.Â
The time needed for Prolopa to produce noticeable improvements depends on the prescribed dosage, severity of Parkinson’s symptoms, and individual response to treatment.
Levodopa is absorbed through the digestive system and begins working after reaching the brain and being converted into dopamine.
Some patients may notice improvements in movement within approximately 30 to 60 minutes after an individual dose.
However, the onset of action may be affected by food, stomach emptying, and other factors.
The full benefit of a newly prescribed treatment schedule may take longer to assess because the dosage is often increased gradually.
Your healthcare provider will monitor your response and adjust treatment to balance symptom relief with possible side effects.
As Parkinson’s disease progresses, some patients may develop fluctuations in how long each dose remains effective.
These fluctuations are sometimes called wearing-off effects.
If your medication begins wearing off before the next scheduled dose, contact your healthcare provider rather than changing your dosage independently.
Prolopa may begin improving movement within an hour of an individual dose, although treatment response varies. Dosage adjustments should always be supervised by your healthcare provider.
Prolopa is available in oral capsule strengths containing levodopa and benserazide, including 50 mg/12.5 mg, 100 mg/25 mg, and 200 mg/50 mg, although product availability may vary.
It is generally taken several times daily according to an individualized treatment schedule.
Common side effects may include nausea, vomiting, dizziness, low blood pressure when standing, and involuntary movements called dyskinesias.
Some patients may also experience hallucinations, sleep disturbances, daytime sleepiness, or sudden episodes of falling asleep.
Long-term treatment may be associated with fluctuations in symptom control and involuntary movements.
Prolopa should not be stopped suddenly because abrupt discontinuation may cause severe worsening of symptoms and, rarely, a potentially life-threatening condition involving fever, muscle rigidity, and changes in consciousness.
Under the Canadian product monograph, Prolopa is indicated for adults older than 25 years and has specific contraindications involving certain medical conditions and medications.
Take Prolopa exactly as prescribed. Do not stop treatment suddenly, increase your dosage, or change the timing of your medication without consulting your healthcare provider.
Prolopa is a prescription medication used to manage the symptoms of Parkinson’s disease, including tremors, muscle stiffness, and slowness of movement.
It contains two active ingredients: levodopa and benserazide. Levodopa is converted into dopamine in the brain, helping improve movement and coordination. Benserazide prevents levodopa from being broken down too early in other parts of the body, allowing more of the medication to reach the brain.
Prolopa is available as oral capsules and is usually taken several times daily, depending on the patient’s symptoms and treatment requirements.
The medication should be taken consistently because maintaining adequate dopamine activity helps control Parkinson’s symptoms throughout the day.
Take Prolopa exactly as prescribed by your healthcare provider. Do not change your dosage, open the capsules, or stop treatment suddenly without medical guidance.
Prolopa should be taken by mouth according to your healthcare provider’s instructions.
Swallow the capsules whole with a glass of water. Do not open, crush, chew, or dissolve the capsules in liquid.
Prolopa is commonly taken with meals or immediately after eating to help reduce nausea and stomach discomfort.
However, protein-rich meals may interfere with levodopa absorption and reduce the medication’s effectiveness in some patients.
If you experience nausea, taking Prolopa with a small, low-protein snack, such as crackers, fruit, or applesauce, may help improve tolerance.
Your healthcare provider may recommend adjusting the timing of your meals if food affects how well the medication controls your symptoms.
Take Prolopa at approximately the same times each day to help maintain consistent symptom control.
Swallow Prolopa capsules whole with water. Taking the medication with a low-protein snack may help reduce nausea without significantly interfering with levodopa absorption.Â
The recommended dosage of Prolopa depends on the severity of Parkinson’s symptoms, previous treatments, and individual response to the medication.
Treatment generally begins with a low dose to reduce the likelihood of side effects.
For patients who have not previously received levodopa, the Canadian prescribing information recommends an initial dose of one Prolopa 100 mg/25 mg capsule once or twice daily.
The healthcare provider may then gradually increase the dosage until adequate symptom control is achieved.
As treatment progresses, the total daily dose is commonly divided into four to six administrations.
However, not every patient requires the same number of doses. Some may need a different schedule depending on their symptoms, medication tolerance, and response throughout the day.
Older adults may require particularly careful dose adjustments because they can be more sensitive to certain side effects.
Do not increase the number of capsules or shorten the time between doses without medical guidance.
Prolopa dosage must be individualized. Treatment usually begins with a lower dose and is increased gradually to balance symptom relief with the risk of side effects.Â
Taking Prolopa at consistent times helps maintain more predictable control of Parkinson’s symptoms.
The medication works by increasing dopamine availability in the brain, which helps regulate movement and coordination.
As the effects of each dose gradually decrease, some patients may experience a return of symptoms before their next scheduled dose.
This may cause increased muscle stiffness, tremors, or difficulty moving.
Taking medication at irregular intervals can make these fluctuations more noticeable.
Your healthcare provider will create a dosing schedule based on how long each dose remains effective.
Using a medication reminder or maintaining a written schedule may help you take your doses consistently.
If you notice that your medication frequently wears off before your next scheduled dose, contact your healthcare provider.
Take Prolopa at the same scheduled times each day. Consistent dosing helps maintain symptom control and may reduce fluctuations in movement.
Yes. Certain foods, particularly those high in protein, may reduce the absorption or effectiveness of levodopa.
Protein-rich foods contain amino acids that can compete with levodopa for transport through the digestive system and into the brain.
As a result, some patients may notice that Prolopa works less effectively when taken with a high-protein meal.
Foods that may influence levodopa response include meat, poultry, fish, eggs, dairy products, beans, and protein supplements.
However, patients should not eliminate protein from their diet without medical advice.
Protein is essential for maintaining muscle strength, supporting tissue repair, and preventing malnutrition.
If protein-rich meals interfere with symptom control, your healthcare provider or dietitian may recommend adjusting meal timing.
Some patients benefit from taking levodopa approximately 30–60 minutes before a protein-rich meal or at least one hour after eating, provided they can tolerate the medication without food.
Others may be advised to distribute protein differently throughout the day.
These changes should be individualized because not everyone experiences food-related absorption problems.
High-protein meals may reduce Prolopa’s effectiveness in some patients. Do not restrict dietary protein without guidance from your healthcare provider or dietitian.Â
Iron supplements may reduce the amount of levodopa absorbed by the body.
This interaction can occur because iron may bind to levodopa in the digestive tract, interfering with its absorption.
As a result, taking iron and Prolopa together may make the medication less effective at controlling Parkinson’s symptoms.
Iron may be present in prescription supplements, over-the-counter iron tablets, and multivitamins containing minerals.
Tell your healthcare provider or pharmacist if you take any of these products.
Your healthcare provider may recommend separating iron supplements and Prolopa by several hours to reduce the interaction.
The appropriate timing depends on your prescribed dosing schedule and nutritional requirements.
Do not stop taking medically necessary iron supplements without consulting your healthcare provider.
Avoid taking iron supplements at the same time as Prolopa. Ask your healthcare provider or pharmacist how to separate the doses safely.Â
Some patients taking Prolopa may experience a return of Parkinson’s symptoms before their next scheduled dose.
This is called the wearing-off effect.
Wearing-off occurs when the beneficial effects of levodopa become shorter or less predictable.
For example, a patient may experience improved movement after taking Prolopa but notice increasing tremors, muscle stiffness, or slowness as the next dose approaches.
These symptoms may become more common as Parkinson’s disease progresses.
The duration of symptom relief can also be affected by medication absorption, meal timing, and other factors.
Your healthcare provider may recommend adjusting the dosing schedule, changing the dose, or adding another medication to improve symptom control.
Keeping a record of when symptoms return may help your healthcare provider identify patterns.
Contact your healthcare provider if Parkinson’s symptoms return before your next Prolopa dose. Do not take extra capsules or shorten the dosing interval without medical advice.
Some patients receiving long-term levodopa treatment may experience sudden changes between periods of good movement and periods of significant stiffness or difficulty moving.
These changes are called on-off fluctuations.
During an on period, the medication is working effectively, allowing the patient to move more easily and perform daily activities.
During an off period, the medication’s benefits decrease, causing symptoms such as muscle stiffness, tremors, or difficulty initiating movement.
Unlike predictable wearing-off effects, on-off fluctuations may occur suddenly and sometimes without a clear relationship to the next scheduled dose.
These changes can affect walking, balance, coordination, and the ability to perform routine tasks.
If you experience sudden periods of reduced mobility, inform your healthcare provider.
Your treatment may need to be adjusted to improve symptom control.
Report sudden changes in movement or periods of severe stiffness to your healthcare provider. On-off fluctuations may require adjustments to your Parkinson’s treatment plan.
If you forget to take a dose of Prolopa, take it as soon as you remember unless it is almost time for your next scheduled dose.
If your next dose is approaching, skip the missed dose and continue with your regular dosing schedule.
Do not take two doses at the same time to make up for a missed dose.
Taking additional levodopa may increase the risk of side effects such as nausea, dizziness, low blood pressure, or involuntary movements.
Missing a dose may cause Parkinson’s symptoms to return temporarily.
If you frequently miss doses or have difficulty following your medication schedule, contact your healthcare provider or pharmacist for advice.
Never double your Prolopa dose to compensate for a missed dose. Resume your normal schedule unless your healthcare provider advises otherwise.Â
No. Prolopa should not be stopped suddenly without consulting your healthcare provider.
Abrupt discontinuation can cause a severe worsening of Parkinson’s symptoms.
In rare cases, suddenly stopping levodopa-containing medications may trigger a potentially life-threatening condition resembling neuroleptic malignant syndrome.
This condition can cause high fever, severe muscle rigidity, confusion, changes in consciousness, and disturbances in heart rate or blood pressure.
Some patients may also experience anxiety, mood changes, or symptoms of depression when dopaminergic treatment is reduced or discontinued.
If treatment needs to be stopped, your healthcare provider will determine how to reduce the dosage safely.
The tapering schedule depends on your current dose, duration of treatment, medical history, and response to dose adjustments.
Do not discontinue Prolopa because your symptoms improve or because you experience a side effect without first obtaining medical advice.
Never stop Prolopa abruptly. Seek emergency medical attention if you develop high fever, severe muscle stiffness, confusion, or a sudden major deterioration in movement after missing or stopping treatment.Â
Prolopa helps manage Parkinson’s symptoms by increasing dopamine availability in the brain.
Although it can improve movement and reduce muscle stiffness, it may cause side effects such as nausea, dizziness, low blood pressure when standing, involuntary movements, and drowsiness.
Some patients may experience hallucinations, changes in behaviour, or sudden episodes of falling asleep.
Avoid driving or operating machinery if you experience excessive sleepiness, dizziness, or unpredictable movement difficulties.
Tell your healthcare provider about all medications and supplements you take, particularly iron-containing products and medications that affect dopamine activity.
Report wearing-off effects, sudden changes in mobility, worsening symptoms, or unusual side effects promptly.
Take Prolopa exactly as prescribed, swallow the capsules whole, maintain a consistent dosing schedule, and never stop treatment suddenly. Regular medical follow-up is essential for safely managing Parkinson’s symptoms.
Prolopa (Levodopa/Benserazide) is available in the following forms and strength:
Prolopa is a prescription medication used to manage the symptoms of Parkinson’s disease, including tremors, muscle stiffness, and slowness of movement.
It contains two active ingredients: levodopa and benserazide. Levodopa is converted into dopamine in the brain, helping improve movement and coordination. Benserazide prevents levodopa from being broken down too early outside the brain, allowing more of the medication to reach its intended destination.
Although Prolopa can improve movement and help patients perform daily activities, it may cause side effects that require careful medical monitoring.
Some patients may experience dizziness, low blood pressure, involuntary movements, hallucinations, or changes in mood and behavior. Certain medical conditions and medications may also increase the risk of serious complications.
Prolopa should only be taken under medical supervision. Inform your healthcare provider about all existing medical conditions, medications, and supplements before starting treatment.Â
Patients with a history of glaucoma should inform their healthcare provider before taking Prolopa.
Glaucoma is an eye condition that can damage the optic nerve, which transmits visual information from the eye to the brain. Elevated pressure inside the eye is an important risk factor for this damage.
Levodopa may affect pressure inside the eye, making treatment unsuitable for certain patients.
Prolopa is contraindicated in patients with narrow-angle glaucoma, meaning they should not use the medication.
Patients with well-controlled open-angle glaucoma may be considered for treatment under specialist supervision, with regular monitoring of eye pressure.
Your healthcare provider may recommend eye examinations before and during treatment.
Report any new visual disturbances, eye pain, or unusual changes in vision.
Do not take Prolopa if you have narrow-angle glaucoma. Patients with open-angle glaucoma should discuss treatment with their healthcare provider and may require regular eye pressure monitoring.Â
Prolopa may interact with certain medications, including antidepressants, antipsychotics, blood pressure medications, and other drugs that affect dopamine activity.
These interactions may reduce the effectiveness of Prolopa or increase the likelihood of adverse effects.
Certain antipsychotic medications block dopamine receptors in the brain. Because Prolopa works by increasing dopamine availability, these medications may interfere with its ability to control Parkinson’s symptoms.
Some antidepressants may also interact with Prolopa.
In particular, nonselective monoamine oxidase inhibitors (MAOIs) must not be taken with Prolopa because the combination can cause dangerous increases in blood pressure and other serious reactions.
A waiting period is generally required when switching from an MAOI to Prolopa.
Other medications may increase dizziness, confusion, hallucinations, or low blood pressure when taken with levodopa.
Your healthcare provider will review your medication list and determine whether dosage adjustments or alternative treatments are necessary.
Tell your healthcare provider about all prescription medications, over-the-counter products, vitamins, and supplements you take. Do not combine Prolopa with contraindicated MAOIs or change psychiatric medications without medical advice.Â
Patients with a history of heart disease should inform their healthcare provider before taking Prolopa.
Levodopa can affect blood pressure and heart rhythm, which may be concerning for patients with certain cardiovascular conditions.
These conditions include angina, previous heart attacks, and irregular heartbeats.
Angina occurs when the heart muscle does not receive enough oxygen-rich blood, causing chest pain or discomfort.
Some patients receiving levodopa may experience palpitations, changes in heart rhythm, or fluctuations in blood pressure.
Patients with a history of heart attack or certain cardiac arrhythmias may require closer monitoring when treatment begins.
Prolopa is contraindicated in patients with uncompensated cardiovascular disease, meaning serious heart disease that is not adequately controlled.
Patients with stable heart conditions may require individualized assessment and monitoring.
Your healthcare provider may recommend blood pressure measurements, electrocardiograms, or other cardiovascular evaluations.
Tell your healthcare provider if you have heart disease, angina, irregular heartbeats, or a history of heart attack. Seek urgent medical attention for chest pain, fainting, or a new serious heart rhythm disturbance.Â
Prolopa may cause dizziness, lightheadedness, or drowsiness, particularly when treatment begins or the dosage increases.
These effects can interfere with concentration, coordination, and the ability to perform activities safely.
Some patients may also experience sudden episodes of falling asleep without warning.
This can be particularly dangerous while driving, operating machinery, or performing tasks that require continuous attention.
Alcohol may worsen dizziness, sleepiness, and impaired coordination.
Other medications that cause drowsiness, such as sleeping pills and certain anxiety medications, may also increase these effects.
Until you know how Prolopa affects you, avoid activities that could become dangerous if you suddenly feel sleepy or lose your balance.
If you experience excessive daytime sleepiness or sudden sleep episodes, contact your healthcare provider.
Avoid alcohol if it worsens dizziness or drowsiness, and do not drive or operate machinery if you experience excessive sleepiness or sudden episodes of falling asleep.Â
Prolopa may cause involuntary movements, known as dyskinesias, particularly during long-term treatment or when higher doses are required.
Dyskinesias are uncontrolled movements that may affect the face, arms, legs, neck, or other parts of the body.
These movements may appear as twisting, writhing, jerking, or repetitive motions.
They can develop when dopamine activity fluctuates during levodopa treatment.
Some patients experience mild movements that do not significantly interfere with daily activities, while others develop more pronounced symptoms.
Dyskinesias may become more noticeable as Parkinson’s disease progresses and the response to levodopa changes.
If involuntary movements develop, your healthcare provider may adjust the dosage, change the timing of administration, or recommend additional treatment.
Do not reduce or stop Prolopa independently because sudden changes may worsen Parkinson’s symptoms.
Contact your healthcare provider if you develop new or worsening involuntary movements. Dosage adjustments may help reduce dyskinesias while maintaining control of Parkinson’s symptoms.
Prolopa may cause a sudden decrease in blood pressure when a patient stands up from a sitting or lying position.
This condition is called orthostatic hypotension.
It occurs when the body cannot adjust blood pressure quickly enough during a change in position.
Symptoms may include dizziness, lightheadedness, blurred vision, weakness, or fainting.
Some patients may also experience difficulty maintaining balance, increasing the risk of falls and injuries.
The risk may be greater when treatment begins, the dosage increases, or Prolopa is combined with blood pressure medications.
To reduce symptoms, stand up slowly after sitting or lying down. If you feel dizzy, sit or lie down until the sensation improves.
Your healthcare provider may recommend checking your blood pressure regularly and reviewing medications that contribute to low blood pressure.
Prolopa may cause orthostatic hypotension. Change positions slowly and contact your healthcare provider if you experience frequent dizziness, fainting, or falls.
Patients with liver disease should inform their healthcare provider before starting Prolopa.
The liver helps process many medications and contributes to several important metabolic functions.
Patients with significant liver impairment may have an increased risk of medication-related complications.
Under the Canadian prescribing information, Prolopa is contraindicated in patients with uncompensated liver disease, meaning liver function is seriously impaired or inadequately controlled.
Patients with a history of liver problems may require additional assessment before treatment begins.
During prolonged treatment, your healthcare provider may recommend periodic liver function tests, particularly if you have other medical conditions or take medications that affect the liver.
Report symptoms such as persistent nausea, unexplained fatigue, dark urine, or yellowing of the skin or eyes.
These symptoms may indicate a liver-related problem that requires medical evaluation.
Tell your healthcare provider if you have liver disease. Patients with uncompensated liver impairment should not use Prolopa, and those with other liver conditions may require additional monitoring.Â
Prolopa may cause or worsen certain psychiatric symptoms, particularly in patients with a history of mental health conditions.
Dopamine plays an important role not only in movement but also in mood, motivation, and behavior.
Because Prolopa increases dopamine availability, some patients may experience changes in thinking, emotions, or behavior during treatment.
Possible symptoms include anxiety, agitation, confusion, hallucinations, and unusual changes in mood.
Hallucinations involve seeing, hearing, or sensing things that are not actually present.
Some patients may also develop paranoid thoughts or other symptoms of psychosis.
Depression can occur in patients with Parkinson’s disease and may be related to the underlying condition, medication effects, or other factors.
Patients with severe psychiatric disorders may not be suitable candidates for Prolopa treatment, particularly when symptoms are uncontrolled.
Your healthcare provider may monitor for changes in mood and behavior throughout treatment.
Family members and caregivers should also report unusual behavioral changes that the patient may not recognize.
Contact your healthcare provider promptly if you experience worsening anxiety, depression, confusion, hallucinations, or unusual behavioral changes. Seek emergency assistance if you develop suicidal thoughts with an immediate risk of self-harm.
Prolopa may also be associated with changes in impulse control.
Impulse control disorders occur when a person experiences strong urges to perform certain activities and has difficulty controlling those behaviors.
Examples include compulsive gambling, excessive shopping, binge eating, and increased sexual urges.
These behaviors may develop during treatment with medications that affect dopamine activity.
Some patients may not recognize that their behavior has changed.
Family members or caregivers may notice unusual spending, increased risk-taking, or repetitive activities that interfere with daily life.
These changes can affect relationships, finances, and overall well-being.
Your healthcare provider may recommend adjusting the medication if significant impulse control problems develop.
Do not stop Prolopa suddenly without medical supervision.
Tell your healthcare provider if you or someone close to you notices new or uncontrollable urges involving gambling, shopping, eating, or other behaviors. These symptoms may be related to dopaminergic treatment.Â
Patients with Parkinson’s disease may have an increased risk of developing melanoma, a serious form of skin cancer.
Melanoma develops when pigment-producing cells in the skin, called melanocytes, begin growing abnormally.
Research has identified an association between Parkinson’s disease and melanoma, although it remains unclear whether this relationship is caused by the disease itself, its treatment, or other factors.
Patients taking Prolopa should inform their healthcare provider if they have a history of melanoma, other skin cancers, or suspicious skin lesions.
Regular skin examinations may be recommended during treatment.
Patients should also monitor their skin for changes in existing moles or the appearance of new, unusual lesions.
Warning signs may include changes in a mole’s size, shape, color, or border, or a lesion that bleeds or fails to heal.
Your healthcare provider may recommend assessment by a dermatologist if suspicious changes are identified.
Patients taking Prolopa should have periodic skin examinations. Report new or changing moles, unusual skin growths, or other suspicious skin lesions promptly.Â
Certain foods, particularly those high in protein, may interfere with the effectiveness of Prolopa.
Levodopa must be absorbed through the digestive system and transported into the brain before it can be converted into dopamine.
Protein-rich foods are broken down into amino acids, some of which compete with levodopa for transport.
As a result, taking Prolopa close to a high-protein meal may reduce or delay its effects in some patients.
Foods that may influence levodopa response include meat, poultry, fish, eggs, dairy products, beans, and protein supplements.
Patients may notice increased stiffness, tremors, or slowness of movement after certain meals.
However, not everyone taking Prolopa experiences significant food-related interactions.
Protein remains an essential part of a healthy diet, particularly for maintaining muscle strength and preventing malnutrition.
Patients should not eliminate or severely restrict dietary protein without medical advice.
If meals interfere with symptom control, your healthcare provider or dietitian may recommend changing the timing of Prolopa doses or redistributing protein intake throughout the day.
High-protein meals may reduce Prolopa’s effectiveness in some patients. Consult your healthcare provider before changing your medication schedule or restricting dietary protein.Â
Patients taking Prolopa should attend regular medical appointments to assess symptom control and identify potential complications.
Your healthcare provider will monitor your response to treatment and determine whether dosage adjustments are necessary.
Monitoring may include blood pressure measurements, assessments of movement and balance, and evaluation of involuntary movements.
Patients with existing medical conditions may also require blood tests or additional examinations.
Your healthcare provider may periodically review liver function, kidney function, blood counts, and cardiovascular health when appropriate.
Changes in mood, sleep patterns, memory, or behavior should also be discussed during follow-up appointments.
As Parkinson’s disease progresses, some patients may develop wearing-off effects or sudden changes between periods of good and poor mobility.
These changes may require adjustments to the treatment schedule.
Do not increase the number of capsules or change the timing of medication without consulting your healthcare provider.
Regular medical follow-up is important for maintaining symptom control, identifying side effects, and safely adjusting Prolopa treatment as Parkinson’s disease progresses.
Prolopa helps manage Parkinson’s disease symptoms by increasing dopamine availability in the brain.
However, treatment may cause dizziness, low blood pressure, involuntary movements, drowsiness, hallucinations, and changes in mood or behavior.
Patients with narrow-angle glaucoma, uncompensated heart or liver disease, or certain severe psychiatric conditions should not use Prolopa.
Patients with a history of melanoma, stable cardiovascular disease, or other significant medical conditions may require additional assessment and monitoring.
High-protein meals and certain medications may also interfere with treatment effectiveness.
Abruptly stopping Prolopa can cause severe worsening of Parkinson’s symptoms and, rarely, a life-threatening reaction involving high fever, muscle rigidity, and confusion.
Never stop Prolopa suddenly or change your dosage without medical supervision. Seek emergency medical attention if you experience severe muscle rigidity with fever, sudden loss of consciousness, chest pain, or other serious symptoms.
Prolopa capsules should generally be swallowed whole with a glass of water. Do not open, crush, chew, or dissolve the capsules in liquid unless your healthcare provider or pharmacist specifically instructs you to do so for your prescribed formulation. Prolopa contains two active ingredients, levodopa and benserazide, which work together to increase dopamine availability in the brain and help manage the movement-related symptoms of Parkinson’s disease. The medication is available in different formulations, and the administration instructions may vary depending on the product prescribed. Standard Prolopa capsules and controlled-release formulations should not automatically be treated as interchangeable. Some patients may experience nausea, vomiting, or stomach discomfort when taking Prolopa, particularly during the early stages of treatment. Taking the medication with a small, low-protein snack may help reduce digestive discomfort. However, protein-rich meals can interfere with levodopa absorption and reduce its effectiveness in some patients. If you have difficulty swallowing capsules, consult your healthcare provider or pharmacist. They may recommend an alternative formulation or another suitable administration method. Swallow Prolopa capsules whole unless instructed otherwise by your healthcare provider. Do not open or dissolve the capsules without confirming that the method is appropriate for your specific formulation.Â
Prolopa typically begins improving Parkinson’s symptoms within approximately 30 to 60 minutes after taking a dose, although the onset of action varies between patients. The medication contains levodopa, which is converted into dopamine after reaching the brain. Dopamine is a chemical messenger that helps control movement, coordination, and muscle activity. As dopamine availability increases, patients may experience improvements in muscle stiffness, tremors, and slowness of movement. However, the time needed for the medication to start working depends on several factors, including the prescribed dosage, formulation, stomach emptying, meal timing, and severity of symptoms. High-protein meals may delay or reduce levodopa absorption in some patients, potentially affecting how quickly symptoms improve. Although individual doses may begin working within an hour, the full benefits of a newly prescribed treatment regimen may take several weeks to assess. This is because healthcare providers often begin treatment with a lower dose and gradually increase it to achieve effective symptom control while minimizing side effects. As Parkinson’s disease progresses, some patients may notice that the medication becomes less effective before their next scheduled dose. This is called the wearing-off effect. If you experience delayed symptom relief, worsening stiffness, or frequent wearing-off effects, contact your healthcare provider. Prolopa may begin improving movement within 30 to 60 minutes, but the full benefits of an adjusted treatment schedule may take several weeks to assess. Do not increase your dosage without medical guidance.
Prolopa may be taken with certain other medications, but some combinations can cause significant drug interactions. Because Prolopa contains levodopa and benserazide, medications that affect dopamine activity, blood pressure, or the nervous system may alter its effectiveness or increase the risk of side effects. Before starting treatment, it is important to inform your healthcare provider about all medications and supplements you are taking. Certain antidepressants may interact with Prolopa, particularly medications known as monoamine oxidase inhibitors (MAOIs). Nonselective MAOIs, such as phenelzine and tranylcypromine, must not be combined with Prolopa because they may cause dangerous increases in blood pressure and other serious complications. However, certain MAO-B inhibitors may be prescribed alongside levodopa to help manage Parkinson’s symptoms. These combinations require careful dosing and medical supervision to minimize potential risks. Antipsychotic medications may also interact with Prolopa because some of these drugs block dopamine receptors in the brain. Since Prolopa works by increasing dopamine availability, combining it with certain antipsychotics may reduce its effectiveness and worsen symptoms such as tremors, muscle stiffness, and slowness of movement. Some combinations may also increase the risk of confusion, hallucinations, or other neurological side effects. Your healthcare provider will determine whether an antipsychotic medication is appropriate and monitor your response to treatment. Prolopa may cause orthostatic hypotension, a condition characterized by a sudden drop in blood pressure when standing up from a sitting or lying position. Taking Prolopa with certain blood pressure medications may increase the likelihood of dizziness, lightheadedness, weakness, or fainting. Patients who experience these symptoms should inform their healthcare provider, as blood pressure monitoring or medication adjustments may be necessary. Iron supplements and multivitamins containing iron may reduce the absorption of levodopa in the digestive tract, potentially making Prolopa less effective at controlling Parkinson’s symptoms. To minimize this interaction, your healthcare provider or pharmacist may recommend taking iron-containing supplements and Prolopa at different times. Do not discontinue prescribed iron supplements without medical advice. Prolopa may also be prescribed alongside other medications used to treat Parkinson’s disease, including dopamine agonists, MAO-B inhibitors, and catechol-O-methyltransferase (COMT) inhibitors. These medications may help improve movement, reduce wearing-off effects, and provide more consistent symptom control. However, combining Parkinson’s medications may also increase the risk of involuntary movements, low blood pressure, hallucinations, excessive drowsiness, or other side effects. Your healthcare provider will carefully adjust the treatment regimen based on your symptoms and individual response. Before taking Prolopa, inform your healthcare provider about all prescription medications, over-the-counter products, vitamins, herbal supplements, and nutritional products you use. This information helps identify potential interactions and ensures that your treatment remains safe and effective. Do not start, stop, or change any medication without consulting your healthcare provider. Prolopa may interact with antidepressants, antipsychotics, blood pressure medications, iron supplements, and other Parkinson’s treatments. Always consult your healthcare provider or pharmacist before combining medications or making changes to your prescribed treatment plan.
| Generic name: | Levodopa/Benserazide |
|---|---|
| Formulation: | Capsule |
| Strength(s): | 50/12.5mg, 200/50mg |
| Quantities Available: | 100 |
Our online Canadian Pharmacy is known for high standards of quality, safety, and efficiency when it comes to medications.
Our pharmacy offers lower prices on prescription drugs compared to traditional pharmacies.
When ordering Prolopa (levodopa/benserazide) from a Canadian pharmacy, you can typically purchase up to a 90-day supply at one time, which is common for prescription medications to ensure adequate management of chronic conditions without frequent refills.
Here’s what you need to know:
Dosage and Quantity: Prolopa is available in dosages of 50 mg/12.5 mg and 200 mg/50 mg (levodopa/benserazide) and is commonly prescribed to be taken 4 to 6 times daily. For example, if you are prescribed a dosage of 200 mg/50 mg taken 4 times daily, then for a 90-day supply you would order 360 capsules (90 days x 4 capsules per day).
No, we do not sell levodopa/benserazide directly on our website. However, you can still enjoy low prices on Prolopa, which contains levodopa/benserazide as active ingredients. To purchase Prolopa, you will need a valid prescription from your healthcare provider. We require this to dispense the medication safely and appropriately. You can submit your prescription by mailing it to us, faxing it, or uploading it through your online account.
Yes, we ship Prolopa (levodopa/benserazide) to both the United States and Puerto Rico.
Watch how Online Pharmacies Canada is helping customers save money on their medications.
Online Pharmacies Canada has provided information from third parties intended to increase awareness and does not contain all the information about Prolopa (Levodopa/Benserazide). Talk to your doctor or other qualified medical practitioners for medical attention or advice, or if you have any concerns about Prolopa (Levodopa/Benserazide).
REVIEWS